The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
HLA class-I antigen presentation machinery (APM) alterations mediate immune evasion in lung cancer brain metastases.
 
Noelia Vilariño
Consulting or Advisory Role - Boehringer Ingelheim
Expert Testimony - Boehringer Ingelheim; MSD Oncology; Roche/Genentech
Travel, Accommodations, Expenses - Boehringer Ingelheim; Roche/Genentech
 
Miguel Lopez De Rodas
No Relationships to Disclose
 
Kishu Ranjan
No Relationships to Disclose
 
Adrien Costantini
No Relationships to Disclose
 
Maria Villalba
No Relationships to Disclose
 
Benjamin Y. Lu
Research Funding - Arcus Biosciences (Inst); Bristol Myers Squibb Foundation (Inst)
 
Caro Kravitz
Stock and Other Ownership Interests - Calithera Biosciences
 
Ernest Nadal
Honoraria - Apollomics
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Janssen Oncology; Lilly; Merck Serono; MSD; Pfizer; Pierre Fabre; Qiagen; Roche; Sanofi; Takeda
Research Funding - Bristol-Myers Squibb (Inst); Merck Serono (Inst); Pfizer (Inst); Roche (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Lilly; MSD; Pfizer; Roche
 
Sarah B. Goldberg
Honoraria - Amgen
Consulting or Advisory Role - AstraZeneca/MedImmune; Daiichi Sankyo; Genzyme; Janssen; Merck; Regeneron; Summit Therapeutics
Research Funding - Amgen (Inst); AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb (Inst); Genentech (Inst); Merck (Inst); Mirati Therapeutics; ORIC Pharmaceuticals (Inst); Pfizer (Inst); Spectrum Pharmaceuticals (Inst)
 
Don Nguyen
Honoraria - Daiichi Sankyo/UCB Japan
Research Funding - AstraZeneca
 
Kurt A. Schalper
Consulting or Advisory Role - Agenus; AstraZeneca; Bristol Myers Squibb; CDR-Life; Clinica Alemana; EMD Serono; Molecular Templates; OnCusp Therapeutics; Parthenon Therapeutics; Roche; Shattuck Labs; Takeda
Speakers' Bureau - Bristol-Myers Squibb; Forefront Collaborative; Genmab; Merck; Peerview; Takeda
Research Funding - Akoya Biosciences (Inst); AstraZeneca; Boehringer Ingelheim (Inst); Bristol-Myers Squibb; Lilly; Merck; Navigate BioPharma; Ribon Therapeutics; Roche (Inst); Surface Oncology; Takeda; Tesaro (Inst)
Patents, Royalties, Other Intellectual Property - Patent No. 16/464,010 (PREDICTION OF RESPONSE TO IMMUNE-MODULATORY THERAPIES)
Expert Testimony - AstraZeneca